Human genetic research: emerging trends in ethics (original) (raw)

References

  1. Knoppers, B. M. & Chadwick, R. The Human Genome Project: under an international ethical microscope. Science 265, 2035–2036 (1994).
    Article CAS PubMed Google Scholar
  2. World Health Organization. Genetic databases: assessing the benefits and the impact on human and patient rights (World Health Organization, Geneva, 2003).
  3. Marteau, T. & Richards, M. (eds) The Troubled Helix: Social and Psychological Implications of the New Genetics (Cambridge Univ. Press, Cambridge, 1996).
    Book Google Scholar
  4. Clarke, A. (ed.) Genetic Counselling: Practice and Principles (Routledge, London, 1994).
    Book Google Scholar
  5. Wertz, D. C. Ethical and legal implications of the new genetics: issues for discussion. Soc. Sci. Med. 35, 495–505 (1992).
    Article CAS PubMed Google Scholar
  6. Danish Council on Ethics. Ethics and mapping of the human genome (Danish Council on Ethics, Copenhagen, 1993).
  7. Nuffield Council on Bioethics. Genetic screening: ethical issues (Nuffield Council on Bioethics, London, 1993).
  8. NIH-DOE Working Group on Ethical, Legal and Social Implications of Human Genome Research. Genetic information and health insurance report of the task force on genetic information and insurance (US National Institutes of Health, Bethesda, 1993).
  9. Committee on the Ethics of Gene Therapy. Report of the committee on the ethics of gene therapy (UK Department of Health, London, 1992).
  10. De Wachter, M. A. M. Ethical aspects of human germ-line gene therapy. Bioethics 7, 166–177 (1993).
    Article PubMed Google Scholar
  11. Pembrey, M. in Ethics in Reproductive Medicine (eds Bromham, D. et al.) 11–20 (Springer, London, 1992).
    Book Google Scholar
  12. National Bioethics Advisory Commission. Cloning human beings (National Bioethics Advisory Council, Rockville, 1997).
  13. Robertson, J. Liberty, identity, and human cloning. Tex. Law Rev. 76, 1371–1456 (1998).
    PubMed Google Scholar
  14. Knoppers, B. M., Hirtle M. & Glass K. C. Commercialization of genetic research and public policy. Science 286, 2277–2278 (1999).
    Article CAS PubMed Google Scholar
  15. Burgess, M. in The Commercialisation of Genetic Research: Legal Ethical and Policy Issues (eds Caulfield, T. & Williams-Jones, B.) 181–194 (Kluwer Academic Plenum, New York, 1999).
    Book Google Scholar
  16. Resnik, D. B. The morality of human gene patents. Kennedy Inst. Ethics J. 7, 43–61 (1997).
    Article PubMed Google Scholar
  17. Estonian Government. Human genes research act (RT I 2000, 104, 685) <http://cmgm.stanford.edu/biochem118/Papers/Genome%20Papers/Estonian%20Genome%20Res%20Act.pdf> (2001).
  18. 123rd Parliament, Iceland. Act on a health sector database no. 139/1998 (1998).
  19. Buchanan, A. et al. Pharmacogenetics — ethical and regulatory issues in research and clinical practice: report of the consortium on pharmacogenetics, findings and recommendations (Consortium on Pharmacogenetics, Minneapolis, 2002).
  20. Nuffield Council on Bioethics. Pharmacogenetics: ethical issues <http://www.nuffieldbioethics.org/fileLibrary/pdf/pharm_short_version2.pdf> (Nuffield Council on Bioethics, London, 2003).
  21. Nuffield Council on Bioethics. The use of genetically modified crops in developing countries <http://www.nuffieldbioethics.org/fileLibrary/pdf/ GM_Crops_short_version_FINAL.pdf> (Nuffield Council on Bioethics, London, 2004).
  22. Bell, J. The new genetics in clinical practice. BMJ 316, 618–620 (1998).
    Article CAS PubMed PubMed Central Google Scholar
  23. Roses, A. D. Pharmacogenetics and future drug development and delivery. Lancet 355, 1358–1361 (2000).
    Article CAS PubMed Google Scholar
  24. Roses, A. D. Pharmacogenetics and the practice of medicine. Nature 15, 857–865 (2000).
    Article Google Scholar
  25. Kegley, J. A. in Genetic Information: Acquisition, Access and Control (eds Thompson, A. & Chadwick, R.) 321–329 (Kluwer Academic, New York, 1997).
    Google Scholar
  26. Beyleveld, D. & Brownsword, R. Human Dignity in Bioethics and Biolaw (Oxford Univ. Press, Oxford, 2001).
    Google Scholar
  27. Gallagher, A. in Genetic Information: Acquisition, Access and Control (eds Thompson, A. & Chadwick, R.) 267–273 (Kluwer Academic, New York, 1997).
    Google Scholar
  28. Baylis, F., Downie, J. & Sherwin, S. in Embodying Bioethics: Recent Feminist Advances (eds Donchin, A. & Purdy, L.) 253–268 (Rowman & Littlefield, New York, 1999).
    Google Scholar
  29. Network of Applied Genetic Medicine. Statement of principles: human genomic research (<http://www.rmga.qc.ca/en/index.htm>/Network of Applied Genetic Medicine, Montreal, 2000).
  30. Deschênes, M., Cardinal, G., Knoppers, B. M. & Glass, K. C. Human genetic research, DNA banking and consent: a question of 'form'? Clin. Genet. 59, 221–239 (2001).
    Article PubMed Google Scholar
  31. UNESCO International Bioethics Committee. International declaration on human genetic data (UNESCO, Paris, 2003).
  32. Beskow, L. et al. Informed consent for population-based research involving genetics. JAMA 286, 2315–2321 (2001).
    Article CAS PubMed Google Scholar
  33. HUGO Ethics Committee. Statement on DNA sampling: control and access <http://www.mext.go.jp/a_menu/shinkou/seimei/genomeshishin/html/ guideline/hugo-e.pdf> (Human Genome Organisation, London, 1998).
  34. Godard, B., ten Kate, L., Evers-Kiebooms, G. & Aymé, S. Population genetic screening programmes: principles, techniques and policies. Eur. J. Hum. Genet. 11 (Suppl. 2), 49–87 (2003).
    Article Google Scholar
  35. DeCode Genetics. Code of ethics (DeCode Genetics, Reykjavik, 2000).
  36. HUGO Ethics Committee. Statement on the principled conduct of genetic research (Human Genome Organisation, London, 1996).
  37. Quebec Network of Applied Genetic Medicine. Statement of principles on the ethical conduct of human genetic research involving populations (Quebec, 2003).
  38. CARTaGENE. CARTaGENE project [online] <http://www.cartagene.qc.ca/en/index.htm> (2003).
  39. Knoppers, B. M. (ed.) Populations and Genetics: Legal and Socio-Ethical Perspectives (Martinus Nijhoff, Leiden, 2003).
    Google Scholar
  40. Knoppers, B. Biobanks: simplifying consent. Nature Rev. Genet. 5, 485 (2004).
    Article CAS PubMed Google Scholar
  41. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioural Research. Screening and counselling for genetic conditions: a report on the ethical, social, and legal implications of genetic screening, counselling, and education programs (US Government Printing Office, Washington DC, 1982).
  42. Clayton, E. W. Ethical, legal, and social implications of genomic medicine. N. Engl. J. Med. 349, 562–569 (2003).
    Article PubMed Google Scholar
  43. The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure. Professional disclosure of familial genetic information. Am. J. Hum. Genet. 62, 474–483 (1998).
  44. World Health Organization. Proposed international guidelines on ethical issues in medical genetics and genetic services (World Health Organization, Geneva, 1998).
  45. McGleenan, T. E. & Wiesing, U. Insurance and genetics: european policy options. Eur. J. Health Law 7, 367–383 (2000).
    Google Scholar
  46. Chadwick, R. Genetics, choice and responsibility. Health, Risk Soc. 1, 293–300 (1999).
    Article Google Scholar
  47. Buchanan, A. et al. From Chance to Choice (Cambridge Univ. Press, Cambridge, 2000).
    Book Google Scholar
  48. Chadwick, R., Levitt, M. A. & Shickle D. (eds) The Right to Know and the Right Not to Know (Aldershot, Ashgate, 1997).
    Google Scholar
  49. Rhodes, R. Genetic links, family ties, and social bonds: rights and responsibilities in the face of genetic knowledge. J. Med. Philos. 23, 10–30 (1998).
    Article CAS PubMed Google Scholar
  50. Berg, K. in Proceedings of the 2nd Symposium of the Council of Europe on Bioethics 122–143 (Council of Europe Press, Strasbourg, 1994).
    Google Scholar
  51. Chadwick, R. et al. Euroscreen 2: Towards Community Policy on Insurance, Commercialization and Public Awareness. J. Med. Philos. 26, 263–272 (2001).
    Article CAS PubMed Google Scholar
  52. McGleenan, T., Wiesing, U. & Ewald, F. (eds) Genetics and Insurance (BIOS Scientific, Oxford, 1999).
    Google Scholar
  53. Chadwick, R. & Berg, K. Solidarity and equity: new ethical frameworks for genetic databases. Nature Rev. Genet. 2, 318–321 (2001).
    Article CAS PubMed Google Scholar
  54. HUGO Ethics Committee. Statement on human genomic databases <http://www.gene.ucl.ac.uk/hugo/HEC_Dec02.html> (Human Genome Organisation, London, 2003).
  55. Titmus, R. M. The Gift Relationship: from Human Blood to Social Policy (Allen & Unwin, London, 1970).
    Google Scholar
  56. Medical Research Council. Report of the Medical Research Council Working Group to develop operational and ethical guidelines, human tissue and biological samples for use in research (Medical Research Council, London, 1999).
  57. Annas, G. J. Rules for research on human genetic variation — lessons from Iceland. N. Engl. J. Med. 342, 1830–1833 (2000).
    Article CAS PubMed Google Scholar
  58. Medical Research Council. Human tissue and biological samples for use in research: operational and ethical guidelines (Medical Research Council, London, 2001).
  59. National Bioethics Advisory Commission. Research involving human biological materials: ethical issues and policy guidance (National Bioethics Advisory Commission, Springfield, 1999).
  60. Turney, J. Public understanding of science. Lancet 347, 1087–1090 (1996).
    Article CAS PubMed Google Scholar
  61. Kerr, A., Cunningham-Burley, S. & Amos, A. The new genetics and health: mobilising lay expertise. Public Underst. Sci. 7, 41–60 (1999).
    Google Scholar
  62. Grove-White, R., Macnaghten, P., Mayer, S. & Wynne, B. Uncertain World: Genetically Modified Organisms, Food and Public Attitudes in Britain (IEPPP, Lancaster Univ., Lancaster, 1997).
    Google Scholar
  63. Levitt, M. The Gene Shop: Evaluation of a Public Education Facility (Univ. Central Lancashire, Preston, 1998).
    Google Scholar
  64. Lenaghan, J. Setting priorities: is there a role for citizen's juries? Br. J. Health Care Manage. 312, 1591–1593 (1996).
    CAS Google Scholar
  65. European Commission. The Europeans and modern biotechnology. Eurobarometer 46 <http://sherlock.mcgill.ca/ENQ–10303/doc/cb6940.pdf> (1997).
  66. Chadwick, R. The Icelandic database — do modern times need modern sagas? BMJ 319, 441–444 (1999).
    Article CAS PubMed PubMed Central Google Scholar
  67. Sveinbjornsdottir, S. et al. Familial aggregation of Parkinson's disease in Iceland. N. Engl. J. Med. 343, 1765–1770 (2000).
    Article CAS PubMed Google Scholar
  68. Knoppers, B. M. Of populations, genetics and banks. Genetics Law Monitor Jan/Feb, 3–6 (2001).
  69. Merz, J. F., McGee, G. E. & Sankar, P. “Iceland Inc.”?: on the ethics of commercial population genomics. Soc. Sci. Med. 58, 1201–1209 (2004).
    Article PubMed Google Scholar
  70. Austin, M. A., Harding, S. & McElroy, C. Genebanks: a comparison of eight proposed international genetic databases. Community Genet. 6, 37–45 (2003).
    PubMed Google Scholar
  71. Medical Research Council. BioBank UK consultation workshop (Medical Research Council, London, 2002).
  72. Haimes, E. What can the social sciences contribute to the study of ethics? Theoretical, empirical and substantive considerations. Bioethics 16, 89–113 (2002).
    Article PubMed Google Scholar
  73. Weiss, K. M. et al. Proposed model ethical protocol for collecting DNA samples. Houst. Law Rev. 33, 1431–1474 (1997).
    CAS PubMed Google Scholar
  74. International HapMap Project. About the International HapMap Project [online] <http://www.hapmap.org/abouthapmap.html.en> (2004).
  75. Parens, E. & Asch, A. The disability rights critique of prenatal genetic testing: reflections and recommendations. Hastings Center Rep. 29, S1–S22 (1999).
    Article CAS Google Scholar
  76. Shakespeare, T. 'Losing the plot'? Medical and activist discourses of contemporary genetics and disability. Sociol. Health Illn. 21, 669–688 (2000).
    Article Google Scholar
  77. Shakespeare, T. Arguing about disability and genetics. Interaction 13, 11–14 (2000).
    Google Scholar
  78. Hull, R. Defining disability — a philosophical approach. Res. Publica. 4, 199–210 (1998)
    Article Google Scholar
  79. UNESCO International Bioethics Committee. Universal declaration on the human genome and human rights (UNESCO, Paris, 1997).
  80. Knoppers, B. M. in The Commercialization of Genetic Research: Ethical, Legal and Policy Issues (eds Caulfield, T. & Williams-Jones, B.) 1–11 (Kluwer Academic Plenum, New York, 1999).
    Book Google Scholar
  81. HUGO Ethics Committee. Statement on benefit sharing (Human Genome Organisation, London, 2000).
  82. Kaul, I., Grunberg, I. & Stern, M. Global Public Goods: International Cooperation in the 21st Century (Oxford Univ. Press, New York, 1999).
    Book Google Scholar
  83. UNESCO. Report by the Director-General on the work of the International Bioethics Committee (IBC) and the Intergovernmental Bioethics Committee (IGBC) (UNESCO, Paris, 2003).
  84. UNESCO. Report by the Director-General on the possibility of elaborating universal norms on bioethics (UNESCO, Paris, 2003).
  85. Editorial. Defining a new bioethic. Nature Genet. 28, 297–298 (2001).
  86. Husted, J. in The Right to Know and the Right Not to Know (eds Chadwick, R., Levitt, M. A. & Shickle, D.) 55–69 (Avebury Press, Aldershot, UK 1997).
    Google Scholar
  87. Tucker, B. P. Deaf culture, cochlear implants, and elective disability. Hastings Center Rep. 28, 6–9 (1998).
    Article CAS Google Scholar
  88. Lippman, A. Genetic testing and screening: constructing needs and reinforcing inequities. Amer. J. Law Med. 17, 15–50 (1991).
    CAS Google Scholar
  89. McGleenan, T. in The Right to Know and the Right Not to Know (eds Chadwick, R., Levitt, M. A. & Shickle, D.) 43–54 (Avebury, Aldershot, UK, 1997).
    Google Scholar

Download references